Page last updated: 2024-11-03

resorcinol and Pain

resorcinol has been researched along with Pain in 4 studies

resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Research Excerpts

ExcerptRelevanceReference
"Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration."8.12Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022)
"Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS."7.76Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010)
"Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration."4.12Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022)
"Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS."3.76Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cordero-Ramos, J1
Merino-Bohórquez, V1
Delgado-Valverde, M1
Barros-Tornay, R1
Cameán-Fenández, M1
Calleja-Hernández, MÁ1
Brizzi, A2
Aiello, F1
Marini, P1
Cascio, MG2
Corelli, F1
Brizzi, V2
De Petrocellis, L1
Ligresti, A1
Luongo, L1
Lamponi, S1
Maione, S2
Pertwee, RG1
Di Marzo, V2
Boer, J1
Jemec, GB1
Bisogno, T1
Palazzo, E1
Thomas, A1
van der Stelt, M1
de Novellis, V1
Marabese, I1
Ross, R1
van de Doelen, T1
Pertwee, R1

Other Studies

4 other studies available for resorcinol and Pain

ArticleYear
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
    European journal of hospital pharmacy : science and practice, 2022, Volume: 29, Issue:6

    Topics: Aluminum; Amber; Chemical Phenomena; Drug Stability; Emulsions; Hidradenitis Suppurativa; Humans; Pa

2022
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
    Bioorganic & medicinal chemistry, 2014, Sep-01, Volume: 22, Issue:17

    Topics: Analgesics; Animals; Calcium Channels; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Dose-R

2014
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:1

    Topics: Adult; Drug Administration Schedule; Female; Hidradenitis Suppurativa; Humans; Middle Aged; Pain; Pa

2010
In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
    British journal of pharmacology, 2006, Volume: 149, Issue:4

    Topics: Action Potentials; Adenylyl Cyclases; Amides; Analgesics; Animals; Brain Stem; CHO Cells; Cricetinae

2006